title: Development of glomerulonephritis early in the course of Crohn's disease.
authors.forename: Erdem
authors.initials: E
authors.lastname: Koçak
authors.forename: Seyfettin
authors.initials: S
authors.lastname: Köklü
authors.forename: Erdem
authors.initials: E
authors.lastname: Akbal
authors.forename: Bülent
authors.initials: B
authors.lastname: Huddam
authors.forename: Alper
authors.initials: A
authors.lastname: Azak
authors.forename: Seref Rahmi
authors.initials: SR
authors.lastname: Yilmaz
mesh_terms: D000328:Adult; D019867:Anti-Glomerular Basement Membrane Disease / Q000209:etiology* / Q000276:immunology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D050533:Glomerular Basement Membrane / Q000276:immunology; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000627:therapeutic use; D011379:Prognosis
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D001323:Autoantibodies; D019804:Mesalamine